Axsome Therapeutics Inc. (AXSM)

NASDAQ: AXSM · Real-Time Price · USD

112.47

0.18 (0.16%)

At close: May 01, 2025, 3:59 PM

114.99

2.24%

After-hours: May 01, 2025, 04:06 PM EDT

Axsome Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	385.69M	270.6M	50.04M	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	33.3M	26.07M	5.2M	1.16M	77.72K	37.33K	48.94K	42.56K	20.48K
Gross Profit	352.39M	244.53M	44.84M	-1.16M	-77.72K	-37.33K	-48.94K	-42.56K	-20.48K
Operating Income	-280.56M	-231.82M	-176.5M	-124.71M	-99.14M	-67.25M	-32.85M	-27.16M	-27.54M
Interest Income	n/a	n/a	7.33M	5.7M	2.57M	1.24M	n/a	n/a	n/a
Pretax Income	-287.13M	-238.28M	-187.13M	-130.4M	-102.9M	-68.35M	-30.97M	-28.94M	-27.2M
Net Income	-287.22M	-239.24M	-197.77M	-134.94M	-105.39M	-69.69M	-30.97M	-28.94M	-27.2M
Selling & General & Admin	411.36M	323.12M	159.25M	66.65M	28.9M	13.6M	9.35M	7.21M	6.34M
Research & Development	187.08M	97.94M	57.95M	58.06M	70.24M	53.65M	23.5M	19.96M	21.2M
Other Expenses	34.52M	55.29M	4.14M	n/a	-53.58K	-139.45K	217.42K	207.11K	474.28K
Operating Expenses	632.95M	476.36M	221.34M	124.71M	99.09M	67.11M	32.63M	26.96M	27.07M
Interest Expense	6.57M	6.45M	7.33M	5.7M	2.57M	1.24M	1.13M	1.34M	132.42K
Selling & Marketing Expenses	n/a	100.3M	35.3M	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	666.25M	502.43M	226.54M	124.71M	99.09M	67.11M	32.63M	26.96M	27.07M
Income Tax Expense	85K	960K	10.63M	4.54M	2.49M	1.34M	3.01M	1.3M	586.22K
Shares Outstanding (Basic)	47.91M	45.43M	40.66M	37.62M	37.21M	34.02M	26.88M	22.76M	19.15M
Shares Outstanding (Diluted)	47.91M	45.43M	40.66M	37.62M	37.21M	34.02M	26.88M	22.76M	19.15M
EPS (Basic)	-5.99	-5.27	-4.86	-3.59	-2.83	-2.05	-1.15	-1.27	-1.42
EPS (Diluted)	-5.99	-5.27	-4.86	-3.59	-2.83	-2.05	-1.15	-1.27	-1.42
EBITDA	-280.56M	-224.99M	-174.23M	-123.55M	-99.06M	-67.21M	-32.58M	-27.77M	-27.52M
EBIT	-280.56M	-231.82M	-179.8M	-124.71M	-100.39M	-67.25M	-32.63M	-27.81M	-27.54M
Depreciation & Amortization	n/a	6.83M	5.56M	1.16M	77.72K	37.33K	48.94K	42.56K	20.48K